Most conversations about medication list accuracy stop at patient safety. For a practice, there are two further exposures that don’t show up on a safety dashboard: the legal risk when a discrepancy causes harm, and the reputational risk when a patient concludes their care was careless. Both are now easier to trigger than they used to be, because patients can read their own records.
Here is what the litigation and reputation evidence says — and why the same fix reduces both.
Medication error is a documented — and growing — source of ambulatory liability
The litigation exposure from outpatient medication error is not hypothetical. It has been measured in closed malpractice claims.
- In a 2011–2021 analysis of medicine-related malpractice claims, anti-infectives, narcotics, and anticoagulants appeared in nearly half of ambulatory medication claims, and clinical judgment and communication were the most common contributing factors (Boisvert, Nelson & Ross, J Patient Saf 2025).
- Ambulatory claims now make up nearly half of all paid malpractice claims — the outpatient setting is no longer the low-risk venue it was once assumed to be (AHRQ PSNet).
- In one analysis, ADEs represented 6.3% of malpractice claims, 73% of them judged preventable, with half of the errors occurring in outpatients and most involving antibiotics, antidepressants, antipsychotics, cardiovascular agents, and anticoagulants (Clinical Errors and Medical Negligence, PMC5586760).
- “Failure to check for drug interactions or allergies” — a direct consequence of an incomplete medication history — is named among the most common medication-related errors in liability analyses (2024 Medical Professional Liability).
The common thread — communication and an incomplete picture of what the patient is actually taking — is exactly the gap an unconfirmed list leaves open.
The relationship, not just the error, predicts whether a patient sues
One of the more durable findings in the malpractice literature is that litigation is not purely a function of harm. Probably no more than 1 in 7 adverse events results in a claim, and among the factors predicting that a patient will resort to litigation is a prior poor relationship with the clinician (PMC5586760).
That reframes medication list accuracy as a relationship asset, not just a documentation task. A patient who was invited to review their list, and whose corrections were taken seriously, enters any subsequent problem as a collaborator. A patient who discovers an uncorrected error alone in a portal enters it as an adversary. The OpenNotes work bears this out from the other direction: when patients flagged possible errors through a feedback tool, 98% reported unchanged or improved relationships with their clinician, and no provider reported a damaged relationship (Bell et al., BMJ Qual Saf 2017).
Transparency changed who sees the error first
Federal rules gave patients direct access to their records, and they read them. In a survey of nearly 30,000 patients, 1 in 5 who read their visit notes reported finding a mistake, and 40% of those considered it serious — with medications among the categories most often flagged as serious (Bell et al., JAMA Netw Open 2020).
For a practice, the strategic point is simple: the error that used to be an internal documentation issue is now something the patient can encounter unsupervised. The only variable the practice still controls is whether that encounter happens with the clinic, before the visit, as a collaboration — or alone, after the fact, as a discovery.
Reputation is now a growth variable — and reviews travel further than any single visit
What a patient concludes about the care they received no longer stays between them and the practice. It goes online, and prospective patients weight it heavily.
- 84% of patients check online reviews before choosing a provider, and more than half read at least six reviews before deciding (rater8 survey, 2025).
- 61% say a negative online review outweighs a personal recommendation (athenahealth).
- 40% of patients report having changed their care plans — canceling an appointment or declining to book — because of negative online feedback (Medical Economics 2026).
- Dissatisfied patients are more likely to post than satisfied ones, which structurally skews a practice’s public reputation toward its worst moments unless it is actively managed (Medical Economics 2026).
A medication mishap — even a near-miss the patient noticed and had to point out — is precisely the kind of experience that becomes a one-star narrative about a practice that “didn’t know what I was taking.” Conversely, being asked to confirm the list before the visit is the kind of small, visible act of diligence that patients read as competence.
The same gesture reduces both exposures at once. Inviting the patient to confirm their list before the visit strengthens the relationship that predicts whether they sue — and creates the impression of diligence that shapes whether they recommend.
What the practice actually controls
- Medication error is a real and growing share of ambulatory malpractice claims, and communication gaps are a leading contributing factor.
- Whether a harmed patient sues depends heavily on the relationship — which is built or broken well before any adverse event.
- Patients now find errors themselves, and medications are among the categories they flag most seriously.
- Online reputation directly drives patient acquisition, and a medication mishap is a natural negative-review trigger.
- Being asked to confirm the list is a low-cost signal of diligence that addresses all of the above at the same point in the workflow.
A note on discipline: none of this establishes that any tool prevents a lawsuit or guarantees a better review. It establishes that inaccurate lists sit upstream of both risks, and that inviting the patient in is the lever a practice actually holds.
ConfirmMyMeds is a working application. It asks the patient to confirm their clinic’s medication list before the appointment, outside the portal, and returns what they confirmed and what they flagged — timestamped and attributed to the person who answered. It produces a point-in-time, patient-attributed record of a medication review, and it never writes to your record; the clinician decides what goes in the chart. We make no claims about litigation or reputation outcomes, because we have no outcome data yet. We’re looking for clinics to tell us where it fails.
This article describes general research on liability and reputation and is not legal advice. Consult your own counsel and malpractice carrier for guidance specific to your practice.